Clinical research activities are focused on the implementation of experimental protocols based on gene or cell therapy
for the treatment of genetic blood disorders such as ADA - SCID, Wiskott - Aldrich Syndrome, Metachromatic Leukodystrophy, Beta - thalassemia, Chronic granulomatous disease,
Mucopolysaccharidosis Type I (Hurler).